| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/13/2009 | CN101432267A Montelukast amantadine salt |
| 05/13/2009 | CN101429160A Synthesis of 1-R-4-amino-1,2,3,4-tetrahydroquinoline |
| 05/13/2009 | CN101429159A Synthesis of 1-R-2,3-dihydrogen-1H-quinoline-4-ketone |
| 05/13/2009 | CN101429158A 2,4-diketone quinoline alkaloid, preparation and uses thereof |
| 05/13/2009 | CN101429157A Process for producing 2-methyl-8-nitryl quinoline |
| 05/13/2009 | CN101429156A Novel methods for producing 1,2,3,4-tetrahydrochysene-4,4-dimethyl quinoline and its derivant |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/12/2009 | US7531663 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 05/12/2009 | US7531656 Synthesis of gatifloxacin |
| 05/12/2009 | US7531554 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 05/12/2009 | US7531553 Heterocyclic compounds and methods of use |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | CA2402742C Method of treating or inhibiting colonic polyps |
| 05/07/2009 | WO2009057668A1 Amide compound and plant disease control using the same |
| 05/07/2009 | WO2009026176A3 Antiinfective flavononol compounds and methods of use thereof |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118329 Novel Substituted 2-Amino-4-Phenyldihydroquinolines, Processes for their Preparation, Pharmaceutical Compositions and Methods for Their Use |
| 05/07/2009 | US20090118324 Mapk/erk kinase inhibitors |
| 05/07/2009 | US20090118290 Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| 05/07/2009 | US20090118282 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 05/07/2009 | US20090118281 Amino Alcohol Derivatives And Their Use As Renin Inhibitor |
| 05/07/2009 | US20090118233 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 05/07/2009 | US20090113639 For coloring keratin fibers, human hair |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1326865B1 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 05/06/2009 | CN101426767A Drying methods of montelukast sodium by azeotropic removal of the solvent |
| 05/06/2009 | CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases |
| 05/06/2009 | CN101423494A Tetrahydro chinolines derivates and synthetic method |
| 05/06/2009 | CN101423493A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/06/2009 | CN101423492A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/05/2009 | US7528254 Reacting the side-chain precursor 1-(mercaptomethyl)cyclopropaneacetic acid (not an ester) with 2-(2-(3S)-(3-(7-chloro-2-quinolinyl)-vinylphenyl)-3-(methanesulfonyloxypropyl)phenyl-2-propanol in a basic solvent mixture; forming an amine salt; and exchanging the amine cation with sodium; 99.5+% pure |
| 05/05/2009 | US7528253 Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 05/05/2009 | CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/05/2009 | CA2267247C Heteroaryloxyethylamines as 5-ht1a ligands |
| 04/30/2009 | WO2009054335A1 Amide compound and method for controlling plant disease using the same |
| 04/30/2009 | WO2009053895A2 Quinoline urotensin-ii receptor antagonists |
| 04/30/2009 | WO2009053424A1 Crystalline salt of montelukast |
| 04/30/2009 | WO2009053373A1 Quinolinone derivatives as parp inhibitors |
| 04/30/2009 | WO2009053250A1 Fungicidal compounds, method for the production thereof, and use thereof to combat damaging fungi, and agents comprising the same |
| 04/30/2009 | WO2009052625A1 Novel crystalline salts of montelukast |
| 04/30/2009 | WO2008115890A3 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2008046598A8 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/30/2009 | WO2007069268A3 A process for the preparation of substantially pure 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives |
| 04/30/2009 | WO2007016609A3 Method for the synthesis of quinoliνe derivatives |
| 04/30/2009 | WO2006014405A3 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 04/30/2009 | US20090111991 Coupling Process For Preparing Quinolone Intermediates |
| 04/30/2009 | US20090111851 Antimicrobial Quinolones, Their Compositions and Uses |
| 04/30/2009 | US20090111850 Amino-Substituted Ethylamino Beta2 Adrenergic Receptor Agonists |
| 04/30/2009 | US20090111849 Crystalline salt of montelukast |
| 04/30/2009 | US20090111829 Aripiprazole Salts |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | CA2702269A1 Fungicidal compounds, processes for their preparation and their use for controlling harmful fungi, and compositions comprising them |
| 04/30/2009 | CA2701723A1 Novel crystalline salts of montelukast |
| 04/29/2009 | EP2053043A1 Crystalline salt of montelukast |
| 04/29/2009 | EP1828154B1 Phenyl-piperazin methanone derivatives |
| 04/29/2009 | EP1771421B1 N-hydroxyamide derivatives and use thereof |
| 04/29/2009 | EP1670769B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/29/2009 | EP1558565B1 Halogenated selective androgen receptor modulators and methods of use thereof |
| 04/29/2009 | EP1461319B1 Quinoline derivatives, synthesis method, and medicines containing said derivatives |
| 04/29/2009 | EP1450806B1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1265640B1 Fluorescent membrane intercalating probes and methods for their use |
| 04/29/2009 | CN101421230A Novel phenyl-propargylether derivatives |
| 04/29/2009 | CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/28/2009 | USRE40703 N-(2-aminophenyl)-4-(N-benzoylaminomethyl)benzamide hydrochloride; differentiation-inducing activity, for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism, hematologic malignancy, a solid carcinoma |
| 04/28/2009 | US7524970 Compounds |
| 04/28/2009 | US7524961 Reacting with N-[(4-chlorophenyl)((4-(3-chlorophenyl)-1-methyl-1H-quinolin-2-one)-6-yl)methylene]-2-methyl-2-propanesulfinamide to form N-[(4-chlorophenyl)((4-(3-chlorophenyl)-1-methyl-1H-quinoline-2-one)-6-yl)(1-methyl-1H-imidazole-5-yl)methyl]-2-methyl-2-propanesulfinamide; Tipifarnib intermediate |
| 04/28/2009 | US7524960 Reacting 6-hydroxy-3,4-dihydroquinolin-2(1H)-one with 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole in the presence of a hydrated inorganic base; free of N-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl]-6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone; purity of at least 99.9%. |
| 04/28/2009 | US7524959 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/28/2009 | US7524862 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence |
| 04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524844 Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them |
| 04/28/2009 | CA2375259C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/28/2009 | CA2259922C Calcium receptor active compounds |
| 04/23/2009 | WO2009052350A1 Amine linked modulators of y-secretase |
| 04/23/2009 | WO2009051096A1 Amide compound and method for controlling plant disease using the same |
| 04/23/2009 | WO2009051086A1 N-benzyl quinoline-6-carboxamide compounds and plant disease controlling method using same |
| 04/23/2009 | WO2009050284A2 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis |
| 04/23/2009 | WO2009049791A2 Radiolabeled nk3 receptor antagonist |
| 04/23/2009 | WO2009049716A2 Novel fungicides |
| 04/23/2009 | WO2009010230A3 Process and intermediate for the production of a tertiary alcohol as an intermediate in the synthesis of montelukast |
| 04/23/2009 | US20090105474 Novel anthranilic acid derivative or salt thereof |
| 04/23/2009 | US20090105310 Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use |
| 04/23/2009 | US20090105300 AMINE LINKED MODULATORS OF y-SECRETASE |
| 04/23/2009 | US20090105299 c-MET MODULATORS AND METHODS OF USE |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105278 Selective inhibitors of human corticosteroid syntheses |
| 04/23/2009 | US20090105272 Prodrugs of modulators of ABC transporters |
| 04/23/2009 | US20090105232 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives |
| 04/23/2009 | CA2703636A1 Amine linked modulators of .gamma.-secretase |
| 04/23/2009 | CA2702859A1 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis |
| 04/23/2009 | CA2696835A1 Novel fungicides |
| 04/22/2009 | EP2049493A2 Compounds suitable as modulators of hdl |
| 04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
| 04/22/2009 | CN101415425A Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |